Projects per year
Fingerprint
Dive into the research topics where Aster Desouter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
AIIFUND84: Continuous monitoring of glycemic variability to predict dys- and hyperglycemia in asymptomatic type 1 diabetes
Keymeulen, B., Desouter, A., Gorus, F., Van de Velde, U. & Uyttenhove, S.
1/04/22 → 31/03/25
Project: Fundamental
-
OZR3630: OZR Back-up mandate: Biomarkers of impending beta cell loss and dysglycemia in asymptomatic type 1 diabetes
1/11/20 → 31/10/21
Project: Fundamental
-
Analyzing Random Forest’s predictive capability for Type 1 Diabetes progression
Cleymans, N. F., Casteele, M. V. D., Vandewalle, J., Desouter, A. K., Gorus, F. K. & Barbè, K., 17 Mar 2025, In: IEEE Open Journal of Instrumentation and Measurement. 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development
Calhoun, P., Spanbauer, C., Steck, A., Frohnert, B., Herman, M., Keymeulen, B., Veijola, R., Toppari, J., Desouter, A., Gorus, F., Atkinson, M. A., Wilson, D., Pietropaulo, S. & Beck, R., 11 Feb 2025, In: Diabetologia.Research output: Contribution to journal › Article › peer-review
-
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis
Desouter, A., Keymeulen, B., Van de Velde, U., Van Dalem, A., Lapauw, B., De Block, C., Gillard, P., Seret, N., Balti, E. V., Van Vooren, E. R. K. P., Staels, W., Van Aken, S., den Brinker, M., Depoorter, S., Marlier, J., Kahya, H. & Gorus, F., 4 Feb 2025, In: Diabetes Care. 48, 4, p. 528-536 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
The stage- and subgroup-specific impact of non-HLA polymorphisms on preclinical type 1 diabetes progression
the Belgian Diabetes Registry, Vandewalle, J., Desouter, A. K., Van der Auwera, B. J., Chapaza, K. B., Nobels, F., Abrams, P., Lebrethon, M. C., Lapauw, B., Keymeulen, B., Gorus, F. K. & Van de Casteele, M., 15 Feb 2025, In: Heliyon. 11, 3, 12 p., e42156.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
74-OR: ADA Presidents' Select Abstract: CGM Metrics from Five Studies Identify Participants at High Risk of Imminent Type 1 Diabetes (T1D) Development
Desouter, A., Calhoun, P., Keymeulen, B., Gorus, F., Spanbauer, C., Steck, A., Diabetes, B., Herman, M., Pietropaulo, S., Wilson, D., Veijola, R., Toppari, J. & Atkinson, M. A., 21 Jun 2024, In: Diabetes. 73, 1 p.Research output: Contribution to journal › Conference paper
Open Access
Prizes
-
FWO Strategic Basic Research Aspirant Fellowship
Desouter, Aster (Recipient), 1 Nov 2021
Prize: Fellowship awarded competitively
Activities
-
Belgisch Diabetes Register
Aster Desouter (Speaker)
11 Mar 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Correlation of risk subgroups with stages in progression to T1D and responsiveness to immune intervention.
Aster Desouter (Speaker)
13 Apr 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Continuous monitoring of glycemic variability to predict dys- and hyperglycemia in asymptomatic type 1 diabetes
Aster Desouter (Contributor) & Bart Keymeulen (Recipient)
1 Apr 2022 → 31 Mar 2025Activity: Other › Written proposal
-
Screening en vroegtijdige behandeling van diabetes type 1: waar staan we?
Aster Desouter (Speaker) & Chantal Mathieu (Speaker)
23 Nov 2022Activity: Talk or presentation › Talk at a public lecture/debate
-
Belgian Diabetes Registry (External organisation)
Aster Desouter (Member)
11 Jul 2019 → 30 Sep 2023Activity: Membership › Membership of external research organisation
Thesis
-
FXR agonist GW4064 protects human beta cells against glucolipotoxicity by FGF19-mediated downregulation of acetyl-coA carboxylase 2 and not by upregulation of stearoyl coenzyme A desaturase
Author: Desouter, A., 2016Supervisor: Hellemans, K. (Promotor)
Student thesis: Master's Thesis